September 29th is World Heart Day...GE Healthcare Signs MOU With Pantomix To Efficiency In Cardiac Testing
Sep 29, 2025
|
According to the 2024 cause of death statistics released by the National Statistical Office, deaths from heart disease are 65.7 per 100,000 people, making it the second-highest cause of death after cancer. In particular, heart disease is evaluated as a disease in which prevention and alertness are important.
In time for World Heart Day, GE Healthcare Korea signed a memorandum of understanding (MOU) with Pantomics, a start-up specializing in AI heart image analysis, to efficiently test and analyze the heart. Employees of both companies, including GE Healthcare Korea CEO Kim Yong-deok, Pantomics CEO Kim Pan-ki, and Yonsei University Severance Hospital professor Choi Byung-wook, attended the signing ceremony.
Through this agreement, the two companies will jointly plan and provide educational materials, clinical guidelines, and workshops applicable to hospital sites, and discuss clinical improvement measures such as improving image quality, shortening filming time, and optimizing protocols suitable for the hospital environment. In addition, each company is in charge of developing joint products by sharing new functions of their solutions, GE Healthcare is in charge of equipment use education, and Pantomics is in charge of heart test and analysis education. In addition, we plan to actively participate in customer meetings and cooperate to create practical value in the actual clinical field.
Pantomics is a start-up related to AI heart image diagnosis established in 2019 and won the CES 2024 Innovation Award for developing an MRI-based heart image analysis solution. Choi Byung-wook, a professor at Yonsei University Severance Hospital, and Dr. Kim Pan-ki, an imaging physicist, are developing a next-generation imaging diagnosis platform that can detect and prevent early based on their expertise in the field of heart imaging.
GE Healthcare has topped the U.S. FDA-approved AI-based medical devices and solutions category for the fourth consecutive year, including Air Recon DL (AIR™ Recon DL), a deep learning-based image reconstruction technology, and Sonic DL™, which received the heart-related technology innovation award at the 2025 Asia MedTech Awards.
Kim Yong-deok, CEO of GE Healthcare Korea, said "Cardiovascular disease is the world's leading mortality rate and the second leading mortality rate after cancer in Korea, and prevention through early detection and diagnosis is very important. It is of even more special significance to announce this agreement on World Heart Day.'GE Healthcare will continue to work with Pantomics to shorten testing time and improve accuracy to contribute to the treatment and prevention of cardiovascular disease patients.'
This article was translated by Naver AI translator.
